Source: Investing Published 12/26/2024, 10:02
In a market that has seen its fair share of volatility, CorVel Corporation (CRVL) stock recently hit a fresh 52-week low, trading at $115.82. With a market cap of $5.95 billion and a current price-to-earnings ratio of 221.3, InvestingPro’s analysis suggests that the stock is trading above its fair value. This price reflects the stock’s lows last year, indicating a significant shift in investor sentiment toward the healthcare management and risk management services company.
Despite this decline, CorVel has seen a significant change over the course of one year, posting a 37.67% increase.
underscoring the stock’s volatile journey and the resilience it has shown over the past 12 months. The company maintains strong fundamentals with an “Excellent” financial health rating and operates with moderate debt. Investors are watching the stock closely as it navigates these challenging market conditions.
looking for signs of stability or potential recovery. InvestingPro subscribers can access 10 additional CRVL investment tips to make more informed decisions.
In other recent news, CorVel Corporation has implemented a three-for-one forward stock split.
a strategic move aimed at making the company’s stock more accessible to a broader investor base. The decision, approved by the board of directors, also includes a proportionate increase in the number of authorized common shares. CorVel, which has demonstrated strong financial performance and strategic initiatives, has seen significant share price growth in recent years.
The distribution of additional shares and the commencement of trading following the split are subject to risks and uncertainties that could cause actual results to differ materially from those projected. CorVel describes these risks in its annual and quarterly reports filed with the Securities and Exchange Commission.
Michael J. Combs, CorVel’s chairman, CEO and president, said the move is a result of the company’s significant share price growth in recent years. The Nasdaq Global Select Market is expected to give final approval soon.
allowing the stock to begin trading on a post-split basis.
These latest developments highlight the company’s strong financial health and robust revenue growth of 12.66% over the past 12 months. Investors should consider the risk factors outlined in CorVel’s annual report and other filings with the Securities and Exchange Commission.
